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Virulence properties of D2794 neuraminidase mutant differ depending 
































































Properties of the PA2794 locus. (A) Sequence predictions for PA2794. 
Shown are the results of structural prediction and sequence similar-
ity searching techniques. The gene PA2794 is depicted 3 times, and 
shaded regions demonstrate distinct functional predictions. Regions 
are indicated using amino acid positions. Predicted transmembrane 
(TM) regions are shown first. These predictions were made using the 
programs TMPred (http://www.ch.embnet.org/software/TMPRED_
form.html) and TMAP (http://bioweb.pasteur.fr/seqanal/interfaces/
tmap.html). The second gene depiction shows the region most simi-
lar to other sialidase genes. Lighter gray shading indicates the region 
predicted by BLAST analysis. For an inclusive definition of the bound-
aries of this region, we used the most extreme amino- and carboxy-
terminal positions of BLAST alignments for the first 50 hits that were 
also labeled as sialidase or neuraminidase genes. The darker shading 
corresponds to the sialidase region predicted by the SMART program 
(http://smart.embl-heidelberg.de/). The third gene depiction shows the 
region similar to autotransporter genes. This region was determined by 
the BLAST alignment with a putative autotransporter (Magn03008734, 
GenBank accession no. ZP_00054112) from the Magnetospiril-
lum magnetotacticum genome. This region had an E value score of 
6 × 10–4 in our BLAST search. (B) Predicted PAO1 neuraminidase 
amino acid sequence. ASP boxes are shaded gray.
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Characterization of the D2794 mutant. (A) Colony PCR for expression 
of nanA. Lanes 2–5 show PCR using primers from within the nanA 
gene; lanes 6–9 show PCR using primers flanking nanA. Lane 2, 
PAO1; lane 3, D2794; lane 4, D2794 + nanA; lane 5, D2794 with vector 
alone; lane 6, PAO1; lane 7, PAK; lane 8, D2794; lane 9, D2794 PAK. 
Lanes 1 and 10 show molecular weight markers. (B) Amount of super-
ficial asialoGM1 on 16HBE cells following exposure to bacterial super-
natant from the indicated strains was quantified by flow cytometry. A 
representative experiment is shown. Unstim, unstimulated (i.e., treated 
with media alone). (C) Growth of strains in M9 media as determined by 
OD600. A representative experiment is shown.
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nization  and  persistence  in  the  airway. 





































Comparison of PAO1 and D2794 virulence. (A–D) Mouse model of pneumonia. (A) The per-
centage of the total number of mice inoculated i.n. with each strain that developed pneumonia 
or bacteremia or died is indicated. (B) KC mRNA expression was determined by real-time PCR 
and standardized to actin. Individual mouse values are shown; horizontal lines indicate the 
median value of each group. (C) Lung cell suspensions from mice inoculated with P. aerugi-
nosa PAO1 or D2794 were stained for CD45 and Ly6G (i.e., PMNs). Leukocytes were gated 
based on CD45 expression, and the percentage of Ly6G-positive cells was determined. Indi-
vidual mouse values are shown; horizontal lines indicate the median value of each group. 
*P < 0.05, Fisher’s exact test (A); nonparametric Mann-Whitney test (B and C). (D) H&E-
stained sections of murine lungs 16 hours following inoculation with P. aeruginosa PAO1 or 
D2794. Arrows demonstrate that airways are full of PMNs in PAO1-infected lung but clear 
in D2794-infected lung. (E) Comparison of PAO1 and D2794 virulence when introduced i.p. 
BALB/c mice (7–10 days old) were inoculated i.p. with PAO1 or D2794 (n = 12 per group). Mice 
were euthanized 16 hours later, and lungs and spleens were harvested for plating of single-cell 
suspensions. The percentage of mice inoculated with each strain that developed pneumonia 
or bacteremia or died is indicated. Pneumonia was defined as the recovery of more than 1,000 
CFU per lung; bacteremia was defined as the presence of bacteria in the spleen.
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Interactions of PAO1 and D2794 with human airway epithelial cells. 
(A) Bacterial adherence following a 1-hour exposure to 16HBE air-
way epithelial cells was determined by flow cytometry. Cells were 
stained with polyclonal anti-OMP followed by Alexa Fluor 488–con-
jugated anti-rabbit IgG. The number of bacteria bound to the surface 
was quantitated as mean fluorescence intensity. (B) Induction of IL-8 
production by confluent monolayers of 1HAEo airway epithelial cells 
following exposure to bacteria — compared with induction by bacte-
rial growth media alone as a control — was quantified by ELISA as 
previously described (57).
Figure 5
Interactions of PAO1 and D2794 with phagocytic cells. (A) Binding and 
phagocytosis of PAO1 and D2794 by RAW cells was determined by 
flow cytometry. Adherent organisms were quantified by staining with 
anti-OMP, and adherent plus internalized bacteria were quantified in 
RAW cells that were permeabilized prior to staining to determine total 
RAW cell–associated bacteria. (B) TNF-α production by RAW cells 
treated with media alone, bacterial culture supernatant, or LPS har-
vested from cultures of PAO1 and D2794 was quantified by ELISA. 
Purified LPS (Sigma-Aldrich) was used as a positive control.
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Comparison of biofilm production by PAO1 and D2794. (A and B) Biofilm production by bacterial strains detected by crystal violet staining. (A) 
PAO1 and D2794 each with either empty control vector (white bars) or cloned nanA (black bars) and (B) PAK, D2794 PAK, D2794 PAK + neur-
aminidase locus (D2794 + nanA), and D2794 PAK plus empty control vector are shown. **P < 0.01, ***P < 0.001, #P < 0.0001 versus PAO1 + 
vector (A) or PAK (B). (C) Fluorescence microscope images (top row) and profiles (bottom row) of biofilm production in a flow cell. Compared with 
PAO1, D2794 formed less differentiated and flattened layers. The D2794 + nanA complemented mutant showed restored, differentiated clumps of 
cells, while the D2794 mutant plus control vector did not. (D) Light microscope images of biofilms produced under more dynamic conditions using 
a rotating disc reactor that uses removable discs attached to a rotor in a chemostat. The disc rotation produces high-shear forces. High-shear 
conditions can accentuate deficiencies in attachment and matrix integrity. White, fluffy material is biofilm. The lack of biofilm formation by the 
mutant could be caused by defective matrix synthesis. (E) Bacteria expressing GFP (106) were incubated with confluent monolayers of 16HBE 
airway epithelial cells for 5 hours and visualized by confocal microscopy.
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Dose-dependent inhibition of biofilm production in response to viral 
neuraminidase inhibitors. PAO1 was grown in the presence of indi-
cated concentrations of (A) oseltamivir and (B) peramivir before plat-
ing for assay, and biofilm production was detected by crystal violet 
staining method. Fold difference compared with untreated is plotted. 
A representative experiment is shown. (C) Inhibition of bacterial neur-
aminidases by peramivir. Purified PAO1 neuraminidase and V. chol-
erae neuraminidase were incubated with and without peramivir, and 
neuraminidase activity was measured using the fluorescent substrate 
2′-(4-methylumbelliferyl)-α-D-N-acetylneuraminic acid. Fold difference 
compared with untreated is plotted. A representative experiment is 
shown. *P < 0.05, **P < 0.01, ***P < 0.001 versus untreated.
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